Cytokinetics, Incorporated (CYTK)

NasdaqGS • Currently up 4.39 (+7.37%) in today's trading session

1 member of Congress has disclosed 2 trades in Cytokinetics, Incorporated (CYTK) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 17 June 2025. Aggregate disclosed activity totals roughly $8K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Cytokinetics, Incorporated is currently trading at $63.97, positioned at 83% of its 52-week range ($29.31 – $70.98).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$63.97
24h Change
+4.39 (+7.37%)
52 Week Range
$29.31—$70.98
View on NASDAQ

Cytokinetics, Incorporated Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CYTK

Select to highlight on chart
0 transactions
Compliance: 0%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$7.88B

Volume

2.67M

Beta

0.48

P/E Ratio

-9.78

Fundamentals

EPS

$-6.54

Div. Yield

—

Open

$59.69

Day Range

$59.69 — $64.30

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Robert I. Blum
IPO Date
2004-04-30
Website
www.cytokinetics.com

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug c...

Earnings

Next Report

Q1 2026

5 May

EPS Est.

$-1.64

Rev. Est.

$8.6M

Days Until

4

Recent Quarters

Q4 202524 Feb
EPS$-1.50
Miss 1.4%
Q3 20255 Nov
EPS$-1.54
Beat 3.1%
Q2 20257 Aug
EPS$-1.12
Beat 16.4%
Q1 20256 May
EPS$-1.36
Beat 3.5%
Q4 202427 Feb
EPS$-1.26
Beat 2.3%
Q3 20246 Nov
EPS$-1.36
Miss 7.1%
Q2 20248 Aug
EPS$-1.31
Miss 28.4%
Q1 20248 May
EPS$-1.33
Miss 14.7%
Q4 202327 Feb
EPS$-1.38
Miss 34.0%
Q3 20232 Nov
EPS$-1.35
Miss 87.5%
Q2 20233 Aug
EPS$-1.34
Miss 8.9%
Q1 20234 May
EPS$-1.38
Miss 11.3%
Q4 20221 Mar
EPS$-1.45
Miss 18.9%
Q3 20223 Nov
EPS$-1.28
Miss 7.6%
Q2 20224 Aug
EPS$-0.23
Beat 77.9%
Q1 20224 May
EPS$-1.02
Miss 9.7%
Q4 202124 Feb
EPS$-0.36
Beat 59.5%
Q3 20213 Nov
EPS$-0.95
Miss 26.7%
Q2 20215 Aug
EPS$-0.86
Miss 32.3%
Q1 20216 May
EPS$-0.66
Miss 11.9%
Q4 202025 Feb
EPS$-0.62
Miss 29.2%
Q3 20204 Nov
EPS$-0.05
Beat 91.5%
Q2 20206 Aug
EPS$-0.68
Miss 19.3%
Q1 20206 May
EPS$-0.66
Miss 32.0%
Q4 20193 Mar
EPS$-0.52
Miss 23.8%
Q3 201931 Oct
EPS$-0.50
Beat 10.7%
Q2 20198 Aug
EPS$-0.56
Miss 5.7%
Q1 20199 May
EPS$-0.54
Miss 14.9%
Q4 201821 Feb
EPS$-0.48
Beat 12.7%
Q3 20181 Nov
EPS$-0.40
Beat 24.5%
Q2 201826 Jul
EPS$-0.51
Miss 4.1%
Q1 201826 Apr
EPS$-0.56
Miss 5.7%
Q4 201715 Feb
EPS$-0.75
Miss 5.6%
Q3 201726 Oct
EPS$-0.60
Beat 6.3%
Q2 20172 Aug
EPS$-0.60
Beat 9.1%
Q1 201727 Apr
EPS$-0.62
Miss 463.6%
Q4 201616 Feb
EPS$0.16
Beat 161.5%
Q3 201627 Oct
EPS$0.74
Beat 355.2%
Q2 201628 Jul
EPS$-0.29
Miss 3.6%
Q1 201628 Apr
EPS$-0.31
Beat 16.2%
Q4 201516 Feb
EPS$-0.24
Beat 25.0%
Q3 201529 Oct
EPS$-0.23
Beat 20.7%
Q2 201529 Jul
EPS$-0.27
Beat 3.6%
Q1 201530 Apr
EPS$-0.23
Miss 187.5%
Q4 201412 Feb
EPS$0.23
Beat 235.3%
Q3 201430 Oct
EPS$-0.16
Beat 40.7%
Q2 201430 Jul
EPS$-0.23
Beat 37.8%
Q1 20146 May
EPS$-0.27
Beat 25.0%
Q4 20136 Feb
EPS$0.21
Beat 362.5%
Q3 201330 Oct
EPS$-0.43
Miss 377.8%
Q2 201331 Jul
EPS$-0.58
Miss 5.5%
Q1 201330 Apr
EPS$-0.54
Beat 0.0%
Q4 20125 Feb
EPS$-0.42
Beat 30.0%
Q3 201230 Oct
EPS$-0.42
Beat 30.0%
Q2 201231 Jul
EPS$-0.78
Miss 2.6%
Q1 201226 Apr
EPS$-0.78
Beat 9.3%
Q4 20112 Feb
EPS$-0.96
Beat 9.4%
Q3 201127 Oct
EPS$-0.90
Beat 23.1%
Q2 201128 Jul
EPS$-1.38
Miss 115.6%
Q1 201127 Apr
EPS$-1.08
Beat 5.3%
Q4 201014 Feb
EPS$-1.02
Beat 23.3%
Q3 201028 Oct
EPS$-1.14
Beat 8.8%
Q2 201028 Jul
EPS$-1.26
Miss 4.1%
Q1 201029 Apr
EPS$-1.20
Miss 0.8%
Q4 20093 Feb
EPS$-1.26
Beat 4.5%
Q3 200928 Oct
EPS$-0.84
Beat 34.9%
Q2 200929 Jul
EPS$5.94
Beat 96.7%
Q1 200930 Apr
EPS$-1.26
Miss 0.8%
Q4 200810 Feb
EPS$-1.32
Beat 43.1%
Q3 200830 Oct
EPS$-1.98
Beat 10.0%
Q2 200831 Jul
EPS$-1.86
Beat 6.5%
Q1 200829 Apr
EPS$-1.68
Beat 11.6%
Q4 200731 Jan
EPS$-1.62
Beat 33.3%
Q3 200731 Oct
EPS$-1.44
Beat 38.7%
Q2 200731 Jul
EPS$-1.62
Beat 25.4%
Q1 200726 Apr
EPS$-1.50
Beat 37.8%
Q4 200631 Jan
EPS$-2.46
Beat 29.5%
Q3 200626 Oct
EPS$-2.46
Beat 18.3%
Q2 200627 Jul
EPS$-2.22
Beat 23.2%
Q1 200627 Apr
EPS$-2.16
Beat 25.8%
Q4 200531 Jan
EPS$-2.28
Beat 19.4%
Q3 200526 Oct
EPS$-2.10
Beat 13.9%
Q2 200527 Jul
EPS$-2.22
Beat 19.0%
Q1 200527 Apr
EPS$-2.22
Beat 17.2%
Q4 20043 Feb
EPS$-2.52
Miss 6.8%
Q3 200412 Nov
EPS$-2.18
Q3 200421 Oct
EPS$-2.16
Beat 25.0%
Q1 200414 Jun
EPS$-15.39
Q3 200331 Dec
EPS$-25.65
Q2 200330 Sept
EPS$-25.65
Q1 200330 Jun
EPS$-24.66
Q4 200231 Mar
EPS$-23.06

No dividend data available for this stock.

Stock Splits

Split History

25 Jun 2013Reverse Split
Ratio1:6

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CYTK

Which members of Congress have traded CYTK?
1 member of Congress has disclosed 2 trade in Cytokinetics, Incorporated (CYTK) under the STOCK Act: Lisa McClain.
When was CYTK most recently disclosed by Congress?
The most recent CYTK disclosure was a sale by Lisa McClain on 17 June 2025.
What is the total disclosed congressional trading volume for CYTK?
Members of Congress have disclosed approximately $8K in CYTK purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in CYTK?
This CYTK page updates as soon as new STOCK Act disclosures are filed for Cytokinetics, Incorporated. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.